Double Medical Technology Inc
Double Medical Technology Inc. engages in the research, development, production, sale, and high-value medical consumables in China. The company provides products for orthopedics, minimally invasive surgery, neurosurgery, wound surgery, and dentistry, etc. It also exports its products to various countries and regions. The company was formerly known as Xiamen Da Bo Ying Jing Medical Equipment Compa… Read more
Double Medical Technology Inc (002901) - Total Liabilities
Latest total liabilities as of September 2025: CN¥1.12 Billion CNY
Based on the latest financial reports, Double Medical Technology Inc (002901) has total liabilities worth CN¥1.12 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Double Medical Technology Inc - Total Liabilities Trend (2013–2024)
This chart illustrates how Double Medical Technology Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Double Medical Technology Inc Competitors by Total Liabilities
The table below lists competitors of Double Medical Technology Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mesa Laboratories Inc
NASDAQ:MLAB
|
USA | $248.16 Million |
|
Farglory Land Development Co Ltd
TW:5522
|
Taiwan | NT$64.70 Billion |
|
Grupo Mateus S.A
SA:GMAT3
|
Brazil | R$12.44 Billion |
|
BSR Real Estate Investment Trust
PINK:BSRTF
|
USA | $832.27 Million |
|
Maharashtra Seamless Limited
NSE:MAHSEAMLES
|
India | ₹7.58 Billion |
|
Amaroq Ltd.
PINK:AMRQF
|
USA | $69.84 Million |
|
Formosa Taffeta Co Ltd
TW:1434
|
Taiwan | NT$16.13 Billion |
|
Canopy Growth Corp
NASDAQ:CGC
|
USA | $348.02 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down Double Medical Technology Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.77 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Double Medical Technology Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Double Medical Technology Inc (2013–2024)
The table below shows the annual total liabilities of Double Medical Technology Inc from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.24 Billion | -16.35% |
| 2023-12-31 | CN¥1.48 Billion | +78.01% |
| 2022-12-31 | CN¥830.88 Million | +4.98% |
| 2021-12-31 | CN¥791.47 Million | +57.14% |
| 2020-12-31 | CN¥503.66 Million | +3.78% |
| 2019-12-31 | CN¥485.31 Million | +134.20% |
| 2018-12-31 | CN¥207.22 Million | +38.33% |
| 2017-12-31 | CN¥149.80 Million | +7.82% |
| 2016-12-31 | CN¥138.93 Million | +16.23% |
| 2015-12-31 | CN¥119.54 Million | -55.88% |
| 2014-12-31 | CN¥270.92 Million | +278.50% |
| 2013-12-31 | CN¥71.58 Million | -- |